Pieris Pharmaceuticals: Q3 Earnings Snapshot
Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of $2.19. This story was generated by Automated Insights ( using data from Zacks Investment Research.
This isn’t the first time Polis, who is seen as a possible 2028 Democratic presidential contender, has shown a willingness to ...
President-elect Trump has tapped anti-vaccine activist and environmental lawyer Robert F. Kennedy Jr. to head the Department ...
Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...
The HHS’ Office for Civil Rights has settled two investigations ... of a 2017 ransomware incident that affected more than ...
HHS shelled out $911,174,285 from taxpayer ... blatant errors, and unfavorable press releases,” the report notes. “Such editing and erasing of guidance and web content on its government ...
For the development of the healthcare cybersecurity one-stop shop, the ASPR seeks $12 million in additional FY 2025 funding ...
Kennedy Jr. to head the Department of Health and Human Services (HHS). HHS has a budget of nearly $2 billion ... Politico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback